{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:48:01Z","timestamp":1760014081379,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2020YFA0710800"],"award-info":[{"award-number":["2020YFA0710800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Program of National Natural Science Foundation of China","award":["81930043"],"award-info":[{"award-number":["81930043"]}]},{"name":"Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health","award":["ZKX18011"],"award-info":[{"award-number":["ZKX18011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10067-021-06035-5","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:02:43Z","timestamp":1643414563000},"page":"1719-1730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis"],"prefix":"10.1007","volume":"41","author":[{"given":"Kai","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rujie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9400-6053","authenticated-orcid":false,"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"6035_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R (2003) Polymyositis and dermatomyositis. Lancet 362:971\u2013982","journal-title":"Lancet"},{"key":"6035_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1136\/annrheumdis-2013-205127","volume":"74","author":"C Dobloug","year":"2015","unstructured":"Dobloug C, Garen T, Bitter H, Stj\u00e4rne J, Stenseth G, Gr\u00f8vle L et al (2015) Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort. Ann Rheum Dis 74:1551\u20131556","journal-title":"Ann Rheum Dis"},{"key":"6035_CR3","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/ard.2008.093161","volume":"68","author":"S Bernatsky","year":"2009","unstructured":"Bernatsky S, Joseph L, Pineau C, B\u00e9lisle P, Boivin J, Banerjee D et al (2009) Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 68:1192\u20131196","journal-title":"Ann Rheum Dis"},{"key":"6035_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/rheumatology\/ket279","volume":"53","author":"P Venalis","year":"2014","unstructured":"Venalis P, Lundberg IE (2014) Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy. Rheumatology 53:397\u2013405","journal-title":"Rheumatology"},{"key":"6035_CR5","doi-asserted-by":"publisher","first-page":"e110044","DOI":"10.1371\/journal.pone.0110044","volume":"9","author":"S Chen","year":"2014","unstructured":"Chen S, Wang Q, Wu Z, Li Y, Li P, Sun F et al (2014) Genetic association study of TNFAIP3, IFIH1, IRF5 polymorphisms with polymyositis\/dermatomyositis in Chinese Han population. PLoS One 9:e110044","journal-title":"PLoS One"},{"key":"6035_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.nmd.2010.06.007","volume":"20","author":"J Heckmann","year":"2010","unstructured":"Heckmann J, Pillay K, Hearn A, Kenyon C (2010) Polymyositis in African HIV-infected subjects. Neuromuscular Disord 20:735\u2013739","journal-title":"Neuromuscular Disord"},{"key":"6035_CR7","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1136\/annrheumdis-2011-200839","volume":"71","author":"T Sugiura","year":"2012","unstructured":"Sugiura T, Kawaguchi Y, Goto K, Hayashi Y, Tsuburaya R, Furuya T et al (2012) Positive association between STAT4 polymorphisms and polymyositis\/dermatomyositis in a Japanese population. Ann Rheum Dis 71:1646\u20131650","journal-title":"Ann Rheum Dis"},{"key":"6035_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2018.1521185","volume":"29","author":"H Kohsaka","year":"2019","unstructured":"Kohsaka H, Mimori T, Kanda T, Shimizu J, Sunada Y, Fujimoto M et al (2019) Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Mod Rheumatol 29:1\u201319","journal-title":"Mod Rheumatol"},{"key":"6035_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","volume":"20","author":"J Vlekkert","year":"2010","unstructured":"Vlekkert J, Hoogendijk J, De Haan R, Algra A, van der Tweel I, Van Der Pol W et al (2010) Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial. Neuromuscular Disord 20:382\u2013389","journal-title":"Neuromuscular Disord"},{"key":"6035_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1136\/annrheumdis-2017-211751","volume":"77","author":"A Tj\u00e4rnlund","year":"2018","unstructured":"Tj\u00e4rnlund A, Tang Q, Wick C, Dastmalchi M, Mann H, Stud\u00fdnkov\u00e1 JT et al (2018) Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial. Ann Rheum Dis 77:55\u201362","journal-title":"Ann Rheum Dis"},{"key":"6035_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/rheumatology\/kew146","volume":"56","author":"S Fasano","year":"2017","unstructured":"Fasano S, Gordon P, Hajji R, Loyo E, Isenberg DA (2017) Rituximab in the treatment of inflammatory myopathies: a review. Rheumatology 56:26\u201336","journal-title":"Rheumatology"},{"key":"6035_CR12","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/RHU.0000000000000807","volume":"25","author":"H Babaoglu","year":"2019","unstructured":"Babaoglu H, Varan O, Atas N, Satis H, Salman R, Tufan A (2019) Tofacitinib for the treatment of refractory polymyositis. J Clin Rheumatol 25:e141\u2013e142","journal-title":"J Clin Rheumatol"},{"key":"6035_CR13","doi-asserted-by":"publisher","first-page":"9163201","DOI":"10.1155\/2016\/9163201","volume":"2016","author":"H Kawasumi","year":"2016","unstructured":"Kawasumi H, Gono T, Kawaguchi Y, Kuwana M, Kaneko H, Katsumata Y et al (2016) Clinical manifestations and myositis-specific autoantibodies associated with physical dysfunction after treatment in polymyositis and dermatomyositis: an observational study of physical dysfunction with myositis in Japan. BioMed Res Int 2016:9163201","journal-title":"BioMed Res Int"},{"key":"6035_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559","journal-title":"BMC Bioinformatics"},{"key":"6035_CR15","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3389\/fimmu.2017.01992","volume":"8","author":"T Sezin","year":"2018","unstructured":"Sezin T, Vorobyev A, Sadik CD, Zillikens D, Gupta Y, Ludwig R (2018) Gene expression analysis reveals novel shared gene signatures and candidate molecular mechanisms between pemphigus and systemic lupus erythematosus in CD4+ T cells. Front Immunol 8:1992","journal-title":"Front Immunol"},{"key":"6035_CR16","doi-asserted-by":"crossref","unstructured":"Wickham R (2016) ggplot2: elegant graphics for data analysis. springer","DOI":"10.1007\/978-3-319-24277-4"},{"key":"6035_CR17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nmeth.2212","volume":"9","author":"R Saito","year":"2012","unstructured":"Saito R, Smoot ME, Ono K, Ruscheinski J, Wang P-L, Lotia S et al (2012) A travel guide to Cytoscape plugins. Nat Methods 9:1069","journal-title":"Nat Methods"},{"key":"6035_CR18","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y (2014) cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol 8:S11","journal-title":"BMC Syst Biol"},{"key":"6035_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12:1\u20138","journal-title":"BMC Bioinformatics"},{"key":"6035_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16:284\u2013287","journal-title":"OMICS"},{"key":"6035_CR21","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter W, S\u00e1nchez-Cabo F, Ricote M (2015) GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics 31:2912\u20132914","journal-title":"Bioinformatics"},{"key":"6035_CR22","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ et al (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313:1929\u20131935","journal-title":"Science"},{"key":"6035_CR23","first-page":"506","volume":"19","author":"A Musa","year":"2018","unstructured":"Musa A, Ghoraie LS, Zhang S-D, Glazko G, Yli-Harja O, Dehmer M et al (2018) A review of connectivity map and computational approaches in pharmacogenomics. Brief Bioinform 19:506\u2013523","journal-title":"Brief Bioinform"},{"key":"6035_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cyto.2012.07.011","volume":"60","author":"H Shen","year":"2012","unstructured":"Shen H, Xia L, Lu J (2012) Pilot study of interleukin-27 in pathogenesis of dermatomyositis and polymyositis: associated with interstitial lung diseases. Cytokine 60:334\u2013337","journal-title":"Cytokine"},{"key":"6035_CR25","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar2885","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg SA (2010) Type 1 interferons and myositis. Arthritis Res Ther 12:S4","journal-title":"Arthritis Res Ther"},{"key":"6035_CR26","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/art.22928","volume":"56","author":"RJ Walsh","year":"2007","unstructured":"Walsh RJ, Kong SW, Yao Y, Jallal B, Kiener PA, Pinkus JL et al (2007) Type I interferon\u2013inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheumatol 56:3784\u20133792","journal-title":"Arthritis Rheumatol"},{"key":"6035_CR27","doi-asserted-by":"publisher","first-page":"e134189","DOI":"10.1172\/jci.insight.134189","volume":"5","author":"N Seto","year":"2020","unstructured":"Seto N, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, et al (2020) Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight 5:e134189","journal-title":"JCI Insight"},{"key":"6035_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/RLU.0b013e3181b53f5a","volume":"34","author":"BR Koppula","year":"2009","unstructured":"Koppula BR, Pipavath S, Lewis DH (2009) Epstein-Barr virus (EBV) associated lymphoepithelioma-like thymic carcinoma associated with paraneoplastic syndrome of polymyositis: a rare tumor with rare association. Clin Nucl Med 34:686\u2013688","journal-title":"Clin Nucl Med"},{"key":"6035_CR29","first-page":"86","volume":"18","author":"T Nojima","year":"2000","unstructured":"Nojima T, Hirakata M, Sato S, Fujii T, Suwa A, Mimori T et al (2000) A case of polymyositis associated with hepatitis B infection. Clin Exp Rheumatol 18:86\u201388","journal-title":"Clin Exp Rheumatol"},{"key":"6035_CR30","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1111\/j.1756-185X.2011.01602.x","volume":"14","author":"MH Wong","year":"2011","unstructured":"Wong MH, Sockalingam S, Zain A (2011) Polymyositis associated with hepatitis B: management with entacavir and prednisolone. Int J Rheum Dise 14:e38\u2013e41","journal-title":"Int J Rheum Dise"},{"key":"6035_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.autrev.2005.05.008","volume":"5","author":"AM Sallum","year":"2006","unstructured":"Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Vianna MA, Sachetti S et al (2006) Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis. Autoimmun Rev 5:93\u2013100","journal-title":"Autoimmun Rev"},{"key":"6035_CR32","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s12035-016-9769-6","volume":"54","author":"W Yan","year":"2017","unstructured":"Yan W, Chen C, Chen H (2017) Estrogen downregulates miR-21 expression and induces inflammatory infiltration of macrophages in polymyositis: role of CXCL10. Mol Neurobiol 54:1631\u20131641","journal-title":"Mol Neurobiol"},{"key":"6035_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08603-9","volume":"7","author":"PD Hamann","year":"2017","unstructured":"Hamann PD, Roux BT, Heward JA, Love S, McHugh NJ, Jones SW et al (2017) Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis. Sci Rep 7:1\u201310","journal-title":"Sci Rep"},{"key":"6035_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13395-019-0194-1","volume":"9","author":"M Llano-Diez","year":"2019","unstructured":"Llano-Diez M, Fury W, Okamoto H, Bai Y, Gromada J, Larsson L (2019) RNA-Sequencing reveals altered skeletal muscle contraction, E3 ligases, autophagy, apoptosis, and chaperone expression in patients with critical illness myopathy. Skelet Muscle 9:9","journal-title":"Skelet Muscle"},{"key":"6035_CR35","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1083\/jcb.140.5.1265","volume":"140","author":"T Jesse","year":"1998","unstructured":"Jesse T, LaChance R, Iademarco M, Dean D (1998) Interferon regulatory factor-2 is a transcriptional activator in muscle where It regulates expression of vascular cell adhesion molecule-1. J Cell Biol 140:1265\u20131276","journal-title":"J Cell Biol"},{"key":"6035_CR36","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1038\/s41467-018-06068-6","volume":"9","author":"B Malecova","year":"2018","unstructured":"Malecova B, Gatto S, Etxaniz U, Passafaro M, Cortez A, Nicoletti C et al (2018) Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy. Nat Commun 9:3670","journal-title":"Nat Commun"},{"key":"6035_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ni809","volume":"3","author":"Y Nagai","year":"2002","unstructured":"Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S et al (2002) Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667\u2013672","journal-title":"Nat Immunol"},{"key":"6035_CR38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/jcp.22053","volume":"223","author":"A Scirocco","year":"2010","unstructured":"Scirocco A, Matarrese P, Petitta C, Cicenia A, Ascione B, Mannironi C et al (2010) Exposure of toll-like receptors 4 to bacterial lipopolysaccharide (LPS) impairs human colonic smooth muscle cell function. J Cell Physiol 223:442\u2013450","journal-title":"J Cell Physiol"},{"key":"6035_CR39","doi-asserted-by":"publisher","first-page":"13997","DOI":"10.1038\/ncomms13997","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Qian Y, Fang Q, Zhong P, Li W, Wang L et al (2017) Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2. Nat Commun 8:13997","journal-title":"Nat Commun"},{"key":"6035_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2017.09.026","volume":"1864","author":"Q Fang","year":"2018","unstructured":"Fang Q, Wang J, Zhang Y, Wang L, Li W, Han J et al (2018) Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis. Biochim Biophys Acta Mol Basis Dis 1864:252\u2013262","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"6035_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10067-009-1316-7","volume":"29","author":"G Kim","year":"2010","unstructured":"Kim G, Cho M, Park Y, Yoo W, Kim J, Oh H et al (2010) Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis. Clin Rheumatol 29:273\u2013279","journal-title":"Clin Rheumatol"},{"key":"6035_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fneur.2017.00132","volume":"8","author":"H Zhang","year":"2017","unstructured":"Zhang H, He F, Shi M, Wang W, Tian X, Kang J et al (2017) Toll-like receptor 4-myeloid differentiation primary response gene 88 pathway is involved in the inflammatory development of polymyositis by mediating interferon-\u03b3 and interleukin-17A in humans and experimental autoimmune myositis mouse model. Front Neurol 8:132","journal-title":"Front Neurol"},{"key":"6035_CR43","doi-asserted-by":"publisher","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","volume":"34","author":"M Chen","year":"2010","unstructured":"Chen M, Daha MR, Kallenberg CG (2010) The complement system in systemic autoimmune disease. J Autoimmun 34:J276\u2013J286","journal-title":"J Autoimmun"},{"key":"6035_CR44","first-page":"237","volume":"49","author":"L Li","year":"2019","unstructured":"Li L, Chen J, Chen S, Liu C, Zhang F, Li Y (2019) Serum C1q concentration positively correlates with erythrocyte sedimentation rate in polymyositis\/dermatomyositis. Ann Clin Lab Sci 49:237\u2013241","journal-title":"Ann Clin Lab Sci"},{"key":"6035_CR45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s004010051165","volume":"99","author":"S Kuru","year":"2000","unstructured":"Kuru S, Inukai A, Liang Y, Doyu M, Takano A, Sobue G (2000) Tumor necrosis factor-\u03b1 expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol 99:585\u2013588","journal-title":"Acta Neuropathol"},{"key":"6035_CR46","doi-asserted-by":"publisher","first-page":"179180","DOI":"10.1155\/2014\/179180","volume":"2014","author":"AMG Brunasso","year":"2014","unstructured":"Brunasso AMG, Aberer W, Massone C (2014) New onset of dermatomyositis\/polymyositis during anti-TNF-\u03b1 therapies: a systematic literature review. Scientific World J 2014:179180","journal-title":"Scientific World J"},{"key":"6035_CR47","doi-asserted-by":"crossref","unstructured":"Schiffenbauer A, Garg M, Castro C, Pokrovnichka A, Joe G, Shrader J, et al. (2018) A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis. Semin Arthritis Rheu. Elsevier","DOI":"10.1016\/j.semarthrit.2017.10.010"},{"key":"6035_CR48","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.4049\/jimmunol.1601011","volume":"198","author":"HJ Fischer","year":"2017","unstructured":"Fischer HJ, Sie C, Schumann E, Witte A-K, Dressel R, van den Brandt J et al (2017) The insulin receptor plays a critical role in T cell function and adaptive immunity. J Immunol 198:1910\u20131920","journal-title":"J Immunol"},{"key":"6035_CR49","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/j.gastro.2007.10.012","volume":"134","author":"EP Cummins","year":"2008","unstructured":"Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG et al (2008) The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134:156\u2013165","journal-title":"Gastroenterology"},{"key":"6035_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/SHK.0b013e318225ad7e","volume":"36","author":"E Hams","year":"2011","unstructured":"Hams E, Saunders SP, Cummins EP, O\u2019Connor A, Tambuwala MT, Gallagher WM et al (2011) The hydroxylase inhibitor DMOG attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B-1 cells. Shock 36:295","journal-title":"Shock"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06035-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-06035-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-06035-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T13:21:51Z","timestamp":1700140911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-06035-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6035"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-06035-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"29 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}